Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dapagliflozin (farxiga) (1 trial)
exenatide (byetta) (1 trial)
Diabetes Mellitus, Type 2 (Phase 4)
Trials (1 total)
Trial APIs (2 total)